Thefinal programs of theForumarenow posted on the2011 ACCITH Forum website.
Under the heading"Final Program"you candownload PDF versionsof: •the programof the GDR private meeting (Monday September 19, afternoon) •the programof the Internationalconference (Tuesday September 20 and Wedneday September 21)
See you soon inStrasbourg-Illkirch!
Registration for theForumis closed sinceThursday1stSeptember.
Registered participants who submitted a summaryof their paperhave been notifiedabout the Scientific Committee choices.
Presentation of the ACCITH research group
The aim of the CNRS research entity "Antibodies and Therapeutic Targeting” (GDR 3260 - ACCITH), comprising 90 participating teams in France, is to bring together scientists from the public and private sectors working on the use of antibodies in human therapy.
The GDR 3260 organizes meetings of scientists in basic and in applied research, and of physicians, to facilitate the application of translational research to the clinic.
Welcome to the 2011 ACCITH Forum
The GDR holds annual scientific meetings for its members, and welcomes the participation of members of the scientific community. This year, the CNRS research unit « Immunology and therapeutic chemistry » (UPR 9021), the joint CNRS - University unit « Biotechnology and cell signalling » (UMR 7242) and Transgene S.A., all GDR-member teams located in Alsace, organize the 2011 ACCITH Forum which will take place on September 19-21, 2011 at the Innovation Center (Pôle API) in Illkirch, near Strasbourg.
The conference will focus on the selection, engineering, preclinical assessment and bioproduction of antibodies used for human therapeutics, and will bring together scientists from the German, Swiss and French Upper Rhine valley area.
Participation in thisforumrequires noregistration fee.
Scientific program
Monday September 19 [2:00 - 7:00 pm] GDR meeting, restricted to GDR members (Discussions will take place in French)
Tuesday September 20 [8:30 am - 7:30 pm]and Wedneday September 21 [8:30 - 12:45 am]International meeting open to the public (Presentations will be in English, participants are required to register)